Copyright
©The Author(s) 2023.
World J Exp Med. Jun 20, 2023; 13(3): 17-27
Published online Jun 20, 2023. doi: 10.5493/wjem.v13.i3.17
Published online Jun 20, 2023. doi: 10.5493/wjem.v13.i3.17
Table 1 Cancer distribution by affected organs and gender
All, n = 6106 | Females, n = 4169 (68.3%) | Males, n = 1937 (31.7%) | |
Breast | 1631 (26.7) | 1560 (37.4) | 71 (3.7) |
Cervix | 1138 (18.6) | 1138 (27.3) | - |
Prostate | 678 (11.1) | - | 678 (35) |
Skin | 356 (5.8) | 186 (4.5) | 170 (8.8) |
Blood and LO | 206 (3.4) | 95 (2.3) | 111 (5.7) |
Uterus | 196 (3.2) | 196 (4.7) | - |
Colon | 173 (2.8) | 92 (2.2) | 81 (4.2) |
Lungs | 161 (2.6) | 60 (1.4) | 101 (5.2) |
Stomach | 112 (1.8) | 45 (1.1) | 67 (3.5) |
Bone | 110 (1.8) | 58 (1.4) | 52 (2.7) |
Thyroid | 106 (1.7) | 84 (2) | 22 (1.1) |
Anus/rectum | 97 (1.6) | 51 (1.2) | 46 (2.4) |
KS | 87 (1.4) | 22 (0.5) | 65 (3.4) |
Soft tissue | 87 (1.4) | 52 (1.2) | 35 (1.8) |
Eye | 77 (1.3) | 35 (0.8) | 42 (2.2) |
Ovary | 77 (1.3) | 77 (1.8) | - |
Mouth | 76 (1.2) | 44 (1.1) | 32 (1.7) |
Vagina | 75 (1.2) | 75 (1.8) | - |
Urinary bladder | 73 (1.2) | 32 (0.8) | 41 (2.1) |
Larynx | 65 (1.1) | 11 (0.3) | 54 (2.8) |
Nose | 62 (1.0) | 28 (0.7) | 34 (1.8) |
Peritoneum | 51 (0.8) | 24 (0.6) | 27 (1.4) |
Liver | 49 (0.8) | 24 (0.6) | 25 (1.3) |
Kidneys | 41 (0.7) | 21 (0.5) | 20 (1) |
Vulva | 41 (0.7) | 41 (1) | - |
Ureter | 33 (0.5) | 14 (0.3) | 19 (1) |
Pharynx/nasopharynx | 33 (0.5) | 19 (0.4) | 14 (0.7) |
Intestines | 29 (0.5) | 16 (0.4) | 13 (0.7) |
Pancreas | 29 (0.5) | 13 (0.3) | 16 (0.8) |
Greater omentum | 22 (0.4) | 15 (0.4) | 7 (0.4) |
Esophagus | 21 (0.3) | 8 (0.2) | 13 (0.7) |
Penis | 20 (0.3) | - | 20 (1) |
Testicles | 20 (0.3) | - | 20 (1) |
Tonsils | 13 (0.2) | 5 (0.1) | 8 (0.4) |
Brain | 10 (0.2) | 6 (0.1) | 4 (0.2) |
Coecum | 10 (0.2) | 4 (0.1) | 6 (0.3) |
Vocal cords | 8 (0.1) | 1 (0.0) | 7 (0.4) |
Ears | 7 (0.1) | 5 (0.1) | 2 (0.1) |
Parotid glands | 7 (0.1) | 2 (0.0) | 5 (0.3) |
Duodenum | 6 (0.1) | 2 (0.0) | 4 (0.2) |
Palate | 4 (0.1) | 4 (0.1) | 0 (0.0) |
Forehead | 2 (0.0) | 1 (0.0) | 1 (0.1) |
Glottis | 2 (0.0) | 0 (0.0) | 2 (0.1) |
Trachea | 2 (0.0) | 1 (0.0) | 1 (0.1) |
Sweat glands | 1 (0.0) | 1 (0.0) | 0 (0.0) |
Maxillary | 1 (0.0) | 1 (0.0) | 0 (0.0) |
Spleen | 1 (0.0) | 0 (0.0) | 1 (0.1) |
- Citation: Bukasa-Kakamba J, Bangolo AI, Bayauli P, Mbunga B, Iyese F, Nkodila A, Atoot A, Anand G, Lee SH, Chaudhary M, Fernandes PQ, Mannam HP, Polavarapu A, Merajunnissa M, Azhar A, Alichetty MN, Singh G, Arana Jr GV, Sekhon I, Singh M, Rodriguez-Castro JD, Atoot A, Weissman S, M’buyamba JR. Proportion of thyroid cancer and other cancers in the democratic republic of Congo. World J Exp Med 2023; 13(3): 17-27
- URL: https://www.wjgnet.com/2220-315x/full/v13/i3/17.htm
- DOI: https://dx.doi.org/10.5493/wjem.v13.i3.17